Physician profile
Corey M Johnson
NPI 1861601916
$9,720.47
in general payments reported to CMS, 2019-2025
46 companies · $2,713 in 2025
The $2,713 reported for 2025 was more than what 85% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,427 · 2020: $416 · 2021: $462 · 2022: $1,373 · 2023: $1,663 · 2024: $1,666 · 2025: $2,713.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,817 · Travel and Lodging: $1,037 · Education: $189.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,816.52 |
| Travel and Lodging | $1,036.88 |
| Education | $189.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,069.64 | 2019-2025 | General - Therapies, Tria Firm, Solyx Sis System |
| Intuitive Surgical, INC. | $1,036.88 | 2025 | |
| Janssen Biotech, INC. | $826.78 | 2019-2025 | Erleada, Rybrevant, Carvykti |
| Pfizer INC. | $753.81 | 2019-2025 | |
| Astellas Pharma US INC | $697.93 | 2019-2025 | Xtandi, Myrbetriq |
| Endo Pharmaceuticals INC. | $592.18 | 2019-2024 | Xiaflex, Aveed |
| Sumitomo Pharma America, INC. | $400.87 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $343.41 | 2019-2025 | |
| Endo USA, INC. | $313.10 | 2024-2025 | Xiaflex, Aveed |
| Axonics, INC. | $295.62 | 2022-2024 | Axonics, Bulkamid |
| Procept Biorobotics Corporation | $256.61 | 2022-2024 | Aquabeam System, Aquabeam Robotic System |
| 180 Medical, INC. | $236.55 | 2019-2025 | |
| Medtronic USA, INC. | $221.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $204.72 | 2022-2025 | |
| Medtronic, INC. | $203.30 | 2022-2023 | Interstim |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Urogen Pharma, INC. | $202.70 | 2023-2025 | Jelmyto |
| Teleflex LLC | $201.58 | 2022-2024 | Urolift |
| C. R. Bard, INC. & Subsidiaries | $197.64 | 2020-2025 | Bard Urinary Drainage Bag, Magic3 Go Intermittent Urinary Catheter |
| Olympus America INC. | $160.97 | 2019-2025 | Itind System, Soltive, Evis Exera III Video System Center |
| Urovant Sciences INC | $137.67 | 2021-2022 | |
| Ethicon US, LLC | $129.79 | 2022-2024 | Monocryl, Stratafix, Evarrest |
| Karl Storz Endoscopy-America | $109.94 | 2023-2024 | Hopkins |
| Progenics Pharmaceuticals, INC. | $103.94 | 2024 | |
| Merck Sharp & Dohme LLC | $93.98 | 2020-2025 | Keytruda, Welireg, Zerbaxa |
| Abiomed | $92.87 | 2025 | |
| Dendreon Pharmaceuticals LLC | $91.27 | 2024-2025 | Provenge |
| Tolmar, INC. | $85.30 | 2023-2024 | |
| Immunitybio, INC. | $84.16 | 2024-2025 | |
| Sun Pharmaceutical Industries INC. | $69.99 | 2022-2023 | Yonsa |
| Blue Earth Diagnostics | $68.98 | 2023-2025 | Posluma |
| Coloplast Corp | $67.02 | 2021-2024 | Altis |
| Calyxo, INC. | $65.68 | 2024-2025 | Cvac Aspiration System |
| Bayer Healthcare Pharmaceuticals INC. | $53.61 | 2021-2025 | |
| Rochester Medical Corporation | $44.40 | 2020 | |
| Myovant Sciences INC. | $30.52 | 2022 | |
| Biotissue Holdings INC. | $22.33 | 2025 | |
| Janssen Pharmaceuticals, INC | $20.14 | 2019 | |
| Palette Life Sciences, INC. | $17.07 | 2022 | |
| Foundation Medicine, INC. | $16.05 | 2023 | Foundationone Cdx |
| Ferring Pharmaceuticals INC. | $15.45 | 2025 | Adstiladrin |
| Neotract INC. | $14.68 | 2019 | |
| Sagent Pharmaceuticals | $14.64 | 2022 | |
| Civco Medical Instruments | $14.19 | 2024 | |
| Photocure INC | $14.01 | 2024 | Cysview |
| Bioprotect Medical, INC. | $13.98 | 2025 | Bioprotect Balloon Implant System |
| Laborie Medical Technologies Corp. | $13.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corey Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.